Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

All Monthly Communication Reports for Actavis Pharma Company

Jean-Guy Goulet, President, Canada & Latin America (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results null-null of 37

  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2016-02-11
    Posted date: 2016-03-09
    Communication number: 233401-370989 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Stella Ambler, Member of parliament | House of Commons
    • Ted Opitz, Member of Parliament | House of Commons
    • Terence Young, Member of Parliament | House of Commons
    • Bernard Trottier, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, International Trade
    Communication date: 2013-01-17
    Posted date: 2013-02-15
    Communication number: 233401-254851 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bernard Trottier, Member of Parliament | House of Commons
    • Patrick Brown, Member of Parliament | House of Commons
    • Nancy Ruth, Senator | Senate of Canada
    • Phil McColeman, Member of Parliament | House of Commons
    • Rob Merrifield, Member of Parliement | House of Commons
    • Devinder Shorey, Member of Parliament | House of Commons
    • Corneliu Chisu, Member of Parliament | House of Commons
    • Chungsen Leung, Member of Parliament | House of Commons
    • Stella Ambler, Member of Parliement | House of Commons
    • Terence Young, Member of Parliement | House of Commons
    • Randy Hoback, Member of Parliement | House of Commons
    • Ted Opitz, Member of Parliement | House of Commons
    • Rick Norlock, Member of Parliement | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-10-02
    Posted date: 2012-11-16
    Communication number: 233401-245673 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bernard Trottier, Member of Parliament | House of Commons

    Subject Matter of the communication: Industry, Intellectual Property, International Trade
    Communication date: 2012-04-26
    Posted date: 2012-05-14
    Communication number: 233401-223239 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kellie Leitch, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-04-26
    Posted date: 2012-05-14
    Communication number: 233401-223237 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ron Cannan, Member of Parliament | House of Commons

    Subject Matter of the communication: Industry, Intellectual Property, International Trade
    Communication date: 2012-04-26
    Posted date: 2012-05-14
    Communication number: 233401-223234 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rob Merrifield, Member of Parliament | House of Commons

    Subject Matter of the communication: Industry, Intellectual Property, International Trade
    Communication date: 2012-04-26
    Posted date: 2012-05-14
    Communication number: 233401-223232 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Eve Adams, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2012-04-16
    Posted date: 2012-05-15
    Communication number: 233401-219587 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Cornelius Chisu, Member of Parliament | House of Commons

    Subject Matter of the communication: Industry, Intellectual Property, International Trade
    Communication date: 2012-03-19
    Posted date: 2012-03-22
    Communication number: 233401-213388 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michelle Boudreau, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Industry, Intellectual Property
    Communication date: 2012-03-02
    Posted date: 2012-04-12
    Communication number: 233401-216567 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bal Gosal, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, International Trade
    Communication date: 2012-02-24
    Posted date: 2012-03-16
    Communication number: 233401-209307 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Joe Oliver, Member of Parliement | House of Commons

    Subject Matter of the communication: Health, International Trade
    Communication date: 2012-02-03
    Posted date: 2012-02-03
    Communication number: 233401-205567 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sean O'Leary, Policy Advisor, Office of the Minister | Industry Canada
    • Christian Paradis, Minister of Industry | Industry Canada

    Subject Matter of the communication: Industry, Intellectual Property, International Trade
    Communication date: 2012-02-02
    Posted date: 2012-03-22
    Communication number: 233401-213387 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Wladyslaw Lizon, Member of Parliament | House of Commons
    • Julian Fantino, Member of Parliment | House of Commons
    • Ted Opitz, Member of Parliament | House of Commons

    Subject Matter of the communication: Industry, International Trade
    Communication date: 2012-01-27
    Posted date: 2012-02-16
    Communication number: 233401-205212 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Stella Amber, Member of Parliament | House of Commons
    • Brad Butt, Member of Parliament | House of Commons
    • Wladyslaw Lizon, Member of Parliament | House of Commons
    • Bal Gosal, Minister of State (Sport) | Canadian Heritage (PCH)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2012-01-25
    Posted date: 2012-02-16
    Communication number: 233401-205213 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Philip Jennings, Associate Assistant Deputy Minister | Industry Canada
    • John Connell, Associate Assistant Deputy Minister | Industry Canada
    • Simon Kennedy, Senior Associate Deputy Minister | Industry Canada

    Subject Matter of the communication: Industry, Intellectual Property, International Trade
    Communication date: 2012-01-12
    Posted date: 2012-02-16
    Communication number: 233401-205215 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Terence Young, Member of parliament | House of Commons

    Subject Matter of the communication: Industry, International Trade
    Communication date: 2012-01-10
    Posted date: 2012-01-23
    Communication number: 233401-204287 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Chris Alexander, MP, Ajax-Pickering | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2011-12-19
    Posted date: 2011-12-19
    Communication number: 233401-200868 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mark Adler, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2011-12-09
    Posted date: 2011-12-12
    Communication number: 233401-198488 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Wladyslaw Lizon, Member of Parliament | House of Commons

    Subject Matter of the communication: Industry, International Trade
    Communication date: 2011-11-18
    Posted date: 2011-11-22
    Communication number: 233401-195824 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kyle Seeback, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2011-11-10
    Posted date: 2011-11-17
    Communication number: 233401-195489 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Lois Brown, Member of Parliament | House of Commons

    Subject Matter of the communication: Intellectual Property, International Trade
    Communication date: 2011-11-09
    Posted date: 2011-11-17
    Communication number: 233401-195469 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Brad Butt, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-10-12
    Posted date: 2011-10-18
    Communication number: 233401-190305 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Brad Butt, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-08-24
    Posted date: 2011-09-14
    Communication number: 233401-185529 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Andrew Saxton, Member of Parliament | House of Commons
    • Blaine Calkins, Member of Parliament | House of Commons
    • Ron Cannan, Member of Parliament | House of Commons
    • Leon Benoit, Member of Parliament | House of Commons
    • Gerry Breitkreuz, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-03-08
    Posted date: 2011-04-16
    Communication number: 233401-169745 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Judy Sgro, Member of Parliament | House of Commons
    • Bryon Wilfert, Member of Parliament | House of Commons
    • Bonnie Crombie, Member of Parliament | House of Commons
    • Kirsty Duncan, Member of Parliament | House of Commons
    • Derek Lee, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-02-15
    Posted date: 2011-03-16
    Communication number: 233401-166110 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Alan Tonks, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-02-15
    Posted date: 2011-03-16
    Communication number: 233401-166109 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Patrick Brown, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2010-10-19
    Posted date: 2010-11-16
    Communication number: 233401-157532 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Tim Uppal, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2010-10-19
    Posted date: 2010-11-16
    Communication number: 233401-157531 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bonnie Crombie, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, Internal Trade
    Communication date: 2010-10-19
    Posted date: 2010-11-16
    Communication number: 233401-157530 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Lee Richardson, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2010-10-19
    Posted date: 2010-11-16
    Communication number: 233401-157529 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kelvin Ogilvie, Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2010-10-19
    Posted date: 2010-11-16
    Communication number: 233401-157528 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Elie Salibi, Policy Advisor | Office of the Minister | Industry Canada

    Subject Matter of the communication: Industry, Intellectual Property
    Communication date: 2010-04-27
    Posted date: 2010-05-25
    Communication number: 233401-148182 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Elie Salibi, Policy Advisor | office of the MInister | Industry Canada

    Subject Matter of the communication: Industry, Intellectual Property
    Communication date: 2009-10-27
    Posted date: 2009-11-16
    Communication number: 233401-127474 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Andrew Wallace, Policy Advisor, Industry and Finance | Prime Minister's Office (PMO)

    Subject Matter of the communication: PMPRB, Industry
    Communication date: 2009-05-05
    Posted date: 2009-06-16
    Communication number: 233401-103034 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Richard Dicerni, Deputy Minister | Industry Canada

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2009-01-14
    Posted date: 2009-02-24
    Communication number: 233401-93458 View monthly communication report
  • Actavis Pharma Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Leona Aglukkaq, Minister of Health | Health Canada (HC)
    • Leah Canning, Policy Advisor | Office of the Minister | Health Canada (HC)
    • Meena Ballantyne, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2009-01-14
    Posted date: 2009-02-24
    Communication number: 233401-93456 View monthly communication report
Date Modified: